513 CCL20 AS POTENTIAL MEDIATOR OF INFLAMMATION AND FIBROSIS IN PATIENTS WITH ALCOHOLIC HEPATITIS: EVIDENCES OF A TRANSLATIONAL STUDY
2013; Elsevier BV; Volume: 58; Linguagem: Inglês
10.1016/s0168-8278(13)60515-2
ISSN1600-0641
AutoresSilvia Affò, Oriol Morales‐Ibanez, Daniel Rodrigo‐Torres, José Altamirano, Dianne H. Dapito, Jorge Matías Caviglia, Vicente Arroyo, Pere Ginés, Joan Caballería, Robert F. Schwabe, Ramón Bataller, Pau Sancho‐Bru,
Tópico(s)Hepatitis C virus research
ResumoPOSTERSthe prognosis of some SVR HCC patients was poor, because of insufficient follow-up, resulting in a delayed diagnosis.3. The age at the start of IFN therapy was significantly inversely correlated with the interval between the end of IFN therapy and carcinogenesis.Conclusions: We recommend that SVR patients be observed at 6-month intervals, to facilitate HCC diagnosis at an early stage, for more than 10 years after the end of IFN therapy, even if these patients are not at an advanced fibrosis stage or cirrhosis.
Referência(s)